Skip to main content

Advertisement

Log in

Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

We recently observed a significantly increased risk for lung cancer in carriers of p53 germline mutations. Because cigarette smoking is known to play an important role in increasing the risk for lung cancer in the general population, we wanted to determine the role of cigarette smoking in lung cancer risk in people with a genetic susceptibility based on a p53 germline mutation. We studied 1263 people from 97 families enrolled in a cohort study of families systematically ascertained through childhood soft-tissue sarcoma patients treated at the M.D. Anderson Cancer Center, University of Texas, between 1944 and 1975. We assessed the incidence of lung and smoking-related cancers in 33 carriers of germline p53 mutations and in 1,230 noncarriers to determine whether there was an association between an inherited cancer predisposition, cigarette smoking, and cancer risk. We analyzed the association between cigarette smoking, mutation status, and lung and other smoking-related cancers by the Kaplan-Meier method and the Cox proportional hazards model with adjustments for birth year, race, and sex. In the hazards model, we incorporated a robust variance estimation to adjust for familial correlation. We observed an increased risk of a variety of histological types of lung cancer in the carriers of the p53 germline mutation. Mutation carriers who smoked had a 3.16-fold (95% confidence interval =1.48–6.78) higher risk for lung cancer than the mutation carriers who did not smoke. Our results demonstrate that cigarette smoking significantly increases lung cancer risk in carriers of a germline p53 mutation. This finding could be useful in designing strategies for early detection and treatment of lung and smoking-related cancers in individuals with this inherited cancer predisposition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  • Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123:21S-49S

    PubMed  Google Scholar 

  • Carbone D (1992) Smoking and cancer. Am J Med 93:13S-17S

    CAS  PubMed  Google Scholar 

  • Data Analysis Products Division (2000) S-PLUS 2000, User's guide; www.stats.ox.ac.uk

  • Doll R (1998) Uncovering the effects of smoking: historical perspective. Stat Methods Med Res 7:87–117

    CAS  PubMed  Google Scholar 

  • Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G (1998) Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family. Hum Genet 102:681–686

    Article  CAS  PubMed  Google Scholar 

  • Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher IM, Bron L, Benhattar J (1995) A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92:3963–3967

    CAS  PubMed  Google Scholar 

  • Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 Mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975–983

    Article  CAS  PubMed  Google Scholar 

  • Kleihues P, Schauble B, Zur HA, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1–13

    CAS  PubMed  Google Scholar 

  • Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA (2000) Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst 92:2037–2039

    Article  CAS  PubMed  Google Scholar 

  • Kondo K, Tsuzuki H, Sasa M, Sumitomo M, Uyama T, Monden Y (1996) A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients. J Surg Oncol 61:20–26

    Article  CAS  PubMed  Google Scholar 

  • Koop CE, Luoto J (1982) The health consequences of smoking: cancer. Overview of a report of the Surgeon General. Public Health Rep 97:318–324

    CAS  PubMed  Google Scholar 

  • Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A (1996) p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 17:2201–2205

    CAS  PubMed  Google Scholar 

  • Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A (1989) High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982–3991

    CAS  PubMed  Google Scholar 

  • Lipsitz SR, Parzen M (1996) A jackknife estimator of variance for Cox regression for correlated survival data. Biometrics 52:291–298

    CAS  PubMed  Google Scholar 

  • Lustbader ED, Williams WR, Bondy ML, Strom S, Strong LC (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet 51:344–356

    Google Scholar 

  • Lynch HT GH (1979) Childhood cancer and the SBLA syndrome. Med Hypotheses 5:15–22

    CAS  PubMed  Google Scholar 

  • Lynch HT, Radford B, Lynch JF (1990) SBLA syndrome revisited. Oncology 47:75–79

    CAS  PubMed  Google Scholar 

  • Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238

    CAS  PubMed  Google Scholar 

  • Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP (2001) Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 10:83–87

    CAS  PubMed  Google Scholar 

  • Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H (1986) Increased familial risk for lung cancer. J Natl Cancer Inst 76:217–222

    CAS  PubMed  Google Scholar 

  • SAS Institute (1994) SAS user's guide: statistics. SAS Institute, Cary, NC

  • Schwartz AG, Rothrock M, Yang P, Swanson GM (1999) Increased cancer risk among relatives of nonsmoking lung cancer cases. Genet Epidemiol 17:1–15

    Article  CAS  PubMed  Google Scholar 

  • Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749

    Google Scholar 

  • Strong LC, Stine M, Norsted TL (1987) Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 79:1213–1220

    CAS  PubMed  Google Scholar 

  • Strong LC, Williams WR, Tainsky MA (1992) The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol 135:190–199

    CAS  PubMed  Google Scholar 

  • Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52:734–736

    CAS  PubMed  Google Scholar 

  • Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252

    PubMed  Google Scholar 

  • Wang SS, Samet JM (1997) Tobacco smoking and cancer: the promise of molecular epidemiology. Salud Publica Mex 39:331–345

    CAS  PubMed  Google Scholar 

  • Zang EA, Wynder EL (1992) Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer 70:69–76

    Google Scholar 

  • Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff GJ, Anderson MW, Wiseman RW, Lubet RA, You M (2000) A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 60:901–907

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thanks B. Mims for germline p53 testing, G. Nesom and V. Williams for editing, G. Robertson and D. Sembera for family contact, G. van der Ven for data collection, M.M. Ater for preliminary analysis, P. Begin for sample collection, and the family members for their kind support. This study was supported by grants from the National Institute of Health (CA 34936 and 5U01 CA 076293 04).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shih-Jen Hwang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, SJ., Cheng, L.SC., Lozano, G. et al. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet 113, 238–243 (2003). https://doi.org/10.1007/s00439-003-0968-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-003-0968-7

Keywords

Navigation